
The crossover will allow all trial participants to receive the vaccine while remaining blinded.

The crossover will allow all trial participants to receive the vaccine while remaining blinded.

India recorded over 100,000 cases on Sunday, the countries highest daily total ever.

The screening methods used in the study proved to be reliable and inexpensive alternatives to the current standard used in testing.

Health regulators in the UK have now found 30 cases involving rare blood clot events after the administration of the AstraZeneca COVID-19 vaccine, but still recommend its use.

The 2 revisions made to the EUA pertain to the number of doses allotted to the current vials containing the vaccine, and allow a new vial that has a maximum of 15 doses.

Investigators discovered that the variant was in many other countries before it was discovered and created a tool to help detect emerging variants in the future.

With the small size and portability of NIRVANA, the test could be used for fast virus detection at various locations and could be used to monitor wastewater or streams for the presence of new viruses.

To date, there have been only a few small reports of seizures in patients with severe COVID-19 and the effects them on patients' health was previously unknown.

TOP1 inhibitors can limit the expression of hyper-inflammatory genes in the lungs of infected animals and improve outcomes days after the initial infection.

The technique will be applicable to a broad set of other diseases and can give doctors a practical method for delineating important differences within disease categories.

President Biden has increased vaccine doses to pharmacies to help speed up inoculations in light of recent infections.

The diagnostic testing kit is easy to use at home and will eventually be able to pick up the thousands of variants of COVID-19.

England starts easing lockdown restrictions in hopes of removing most by early summer.

The pinprick test can accurately measure in under one hour concentrations of coronavirus antibodies in blood and is cheaper than the market gold standard.

The therapy showed significant efficacy in a Phase 3 trial and may be more difficult for variants to develop a resistance against.

The investigators plan to continue testing their method with the ultimate goal of developing a free online platform for medical image classification.

People who experienced COVID-19 symptoms and had the virus in their saliva were more likely to report loss of taste and smell, suggesting that oral infection might underlie oral symptoms.

The phase 2b-3 trial analyzing the efficacy of the ALVAC–gp120 regimen showed that it did not prevent an HIV-1 infection among the participants in the study at 24 months.

The study also provided insight into potential differences between the immune response elicited by the two mRNA vaccines created by Pfizer and Moderna.

Tilorone, quinacrine and pyronaridines effectiveness depended on whether they were used in human-derived cell lines or monkey derived cell lines.

Survivors of the disease have been found to be at an increased risk of blood clots or strokes due to a prolonged immune response caused by the virus.

More respondents with an infection reported daily burnout than those who did not have one.

People who received their vaccine were also significantly less likely to require hospitalization.

Levels of interferon gene activity were much lower in those with the missense mutation.

Regeneron announces results from Phase 3 trial of its monoclonal antibody treatment.

New polls shows confidence in AstraZeneca vaccine plummets in Europe.

8% of ischemic stroke patients had atrial fibrillation, while 9% of those without stroke also had atrial fibrillation.

Machine learning is a promising and potentially powerful technique for detection and prognosis of disease.

Approaches that measure the indirect effect of the virus on the host may offer complementary solutions in clinical or mass testing.

The US was poised in many ways to handle a public health emergency, but the attempt was largely a failure. What happened and how can we push forward?